Anika Therapeutics, Inc. (FRA:AKP)

Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	57.99	55.63	68.74	86.33	94.39	95.82
Short-Term Investments	-	-	-	-	-	2.5
Cash & Short-Term Investments	57.99	55.63	68.74	86.33	94.39	98.32
Cash Growth	-7.02%	-19.07%	-20.37%	-8.54%	-4.00%	-46.84%
Receivables	22.19	23.59	26.36	34.63	29.84	24.1
Inventory	16.28	23.81	24.43	39.77	36.01	46.21
Prepaid Expenses	5.13	5.49	7.48	8.83	8.29	8.75
Other Current Assets	-	5.13	36.31	-	-	-
Total Current Assets	101.59	113.65	163.31	169.55	168.53	177.38
Property, Plant & Equipment	64.91	64.68	65	78.98	68.56	73.23
Goodwill	8.05	7.13	7.57	7.34	7.78	8.41
Other Intangible Assets	1.65	2.49	2.58	74.6	82.38	91.16
Long-Term Deferred Tax Assets	1.25	1.18	1.49	1.45	-	-
Other Long-Term Assets	5.51	7.68	30.69	17.22	20.29	15.42
Total Assets	189.44	202.74	270.63	349.13	347.54	365.61
Accounts Payable	4.73	5.62	6.19	9.07	7.63	8.98
Accrued Expenses	11.88	11.59	11	15.96	16.13	13.21
Current Portion of Leases	1.73	1.92	1.83	2.07	1.71	1.59
Current Income Taxes Payable	-	0.06	1.24	0.81	-	-
Other Current Liabilities	0.75	4.12	10.8	-	4.32	13.09
Total Current Liabilities	19.09	23.31	31.06	27.91	29.8	36.87
Long-Term Leases	22.78	24.01	25.92	28.82	19.24	20.88
Long-Term Deferred Tax Liabilities	-	-	-	6.44	10.16	11.9
Other Long-Term Liabilities	0.76	1.43	1.39	0.4	1.26	23.56
Total Liabilities	42.63	48.75	58.37	63.57	60.45	93.21
Common Stock	0.14	0.14	0.15	0.15	0.14	0.14
Additional Paid-In Capital	91.11	88.96	90.01	81.14	67.08	55.36
Retained Earnings	60.5	71.67	128.05	210.72	225.58	221.44
Comprehensive Income & Other	-4.94	-6.78	-5.94	-6.44	-5.72	-4.54
Shareholders' Equity	146.81	153.99	212.27	285.56	287.09	272.4
Total Liabilities & Equity	189.44	202.74	270.63	349.13	347.54	365.61
Total Debt	24.51	25.93	27.74	30.89	20.95	22.46
Net Cash (Debt)	33.48	29.7	41	55.44	73.43	75.85
Net Cash Growth	-3.88%	-27.57%	-26.05%	-24.51%	-3.19%	-53.30%
Net Cash Per Share	2.32	2.02	2.80	3.81	5.02	5.33
Filing Date Shares Outstanding	14.42	14.18	14.66	14.63	14.47	14.33
Total Common Shares Outstanding	14.42	14.42	14.66	14.63	14.44	14.33
Working Capital	82.5	90.35	132.25	141.63	138.73	140.52
Book Value Per Share	10.18	10.68	14.48	19.53	19.88	19.01
Tangible Book Value	137.1	144.37	202.12	203.63	196.92	172.83
Tangible Book Value Per Share	9.51	10.01	13.79	13.92	13.64	12.06
Machinery	49.39	42.9	44.39	54.53	51.19	50.81
Construction In Progress	4.01	6.04	2.39	5.02	1.38	0.43
Leasehold Improvements	37.85	36.34	34.65	34.92	34.61	34.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.